Assessment of 1863 GRIN2A Variants Contradicts a Role in Tumorigenesis
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26125558 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Robin-Tobias Jauss und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Human Genetics, University of Leipzig Medical Center, 04103 Leipzig, Germany. Hauptthemen laut MEDLINE: Receptors, N-Methyl-D-Aspartate, Carcinogenesis, Neoplasms. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
GRIN2A has previously been identified as frequently mutated in tumor samples, leading to a hypothesized involvement of GRIN2A in tumorigenesis. Pathogenic GRIN2A germline variants, on the other hand lead, to neurodevelopmental disorders, with no evidence for tumor burden. Thus, we aimed for an independent assessment of somatic and germline variation in GRIN2A, hypothesizing that a distinct distribution of somatic variation indicates a tumorigenic effect. All publicly available GRIN2A variants were obtained from ClinVar, gnomAD and Cosmic to account for germline variation in affected individuals and the general population, as well as somatic variation. Functional consequences, mutational hotspots and gene expression were assessed for each dataset to draw conclusions on the potential pathomechanisms of tumorigenesis. Pathogenic germline variants in GRIN2A expose a clear genotype–phenotype association and are predominantly present in functionally relevant domains, while somatic GRIN2A variants exhibit a uniform distribution and no high abundance in functionally relevant domains. The expression of GRIN2A is lower in tumor samples compared to in non-diseased tissues. Given the non-uniform distribution and domain clustering, our results suggest that specific domains of GRIN2A are highly intolerant towards germline variation, while a lack of somatic mutational clustering and functional relevance refutes the previously hypothesized major role of GRIN2A in tumorigenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Human Genetics, University of Leipzig Medical Center, 04103 Leipzig, Germany.
- Center for Rare Diseases, University of Leipzig Medical Center, 04103 Leipzig, Germany.
ORCID-Profile: Robin-Tobias Jauss
Zitieren
APA
Jauss, R. T., Lemke, J. R., & Strehlow, V. (2025). Assessment of 1863 GRIN2A Variants Contradicts a Role in Tumorigenesis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26125558
Vancouver
Jauss RT, Lemke JR, Strehlow V. Assessment of 1863 GRIN2A Variants Contradicts a Role in Tumorigenesis. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26125558
BibTeX
@article{Jauss2025,
author = {Jauss, Robin-Tobias and Lemke, Johannes R and Strehlow, Vincent},
title = {Assessment of 1863 GRIN2A Variants Contradicts a Role in Tumorigenesis},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26125558}
}
EUVIMED